Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDGenmab A/S Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | $1.45 | $1.83 | $1.62 |
| Q2 2025 | 1 | $2.27 | $2.86 | $2.54 |
| Q3 2025 | 5 | $2.64 | $3.48 | $3.09 |
| Q4 2025 | 5 | $2.50 | $3.89 | $3.12 |
| Q1 2026 | 2 | $1.76 | $2.60 | $2.21 |
| Q2 2026 | 1 | $3.14 | $3.96 | $3.51 |
| Q3 2026 | 1 | $3.37 | $4.25 | $3.77 |
| Q4 2026 | 1 | $2.93 | $3.69 | $3.28 |
| Q1 2027 | 1 | $1.48 | $1.87 | $1.66 |
| Q2 2027 | 1 | $2.69 | $3.39 | $3.00 |
| Q3 2027 | 1 | $2.86 | $3.60 | $3.19 |
| Q4 2027 | 1 | $3.06 | $3.86 | $3.42 |
Genmab A/S Earnings Date And Information
Genmab A/S last posted its earnings results on Thursday, November 6th, 2025. The company reported $0.65 earnings per share for the quarter, topping analysts' consensus estimates of $0.48 by $0.17. The company had revenue of 1.02 B for the quarter and had revenue of 21.53 B for the year. Genmab A/S has generated $12 earnings per share over the last year ($12.14 diluted earnings per share) and currently has a price-to-earnings ratio of 14.75. Genmab A/S has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 6th, 2025 based on prior year's report dates.
Genmab A/S Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2025 | Q3 2025 | $0.48 | $0.65 | 0.17 | $6.30 B | $1.02 B |
| 08/07/2025 | Q2 2025 | $0.39 | $3.45 | 3.06 | $5.75 B | $5.86 B |
| 05/08/2025 | Q1 2025 | $0.23 | $0.31 | 0.08 | N/A | $715.00 M |
| 02/12/2025 | Q4 2024 | $0.28 | $5.99 | 5.71 | N/A | $6.44 B |
| 11/06/2024 | Q3 2024 | $0.35 | $1.95 | 1.6 | $5.53 B | $5.54 B |
| 08/08/2024 | Q2 2024 | $0.29 | $2.17 | 1.88 | $5.08 B | $779.00 M |
| 05/02/2024 | Q1 2024 | $0.16 | $2.03 | 1.87 | N/A | $603.00 M |
| 02/14/2024 | Q4 2023 | $0.34 | $0.98 | 0.64 | N/A | $4.68 B |
| 11/07/2023 | Q3 2023 | $3.14 | $3.26 | 0.12 | $4.55 B | $4.71 B |
| 08/03/2023 | Q2 2023 | $2.18 | $2.08 | -0.1 | $4.10 B | $4.17 B |
| 05/10/2023 | Q1 2023 | $0.65 | $0.32 | -0.33 | $2.77 B | $2.83 B |
| 02/22/2023 | Q4 2022 | $3.15 | $0.90 | -2.25 | $4.71 B | $5.14 B |
| 11/09/2022 | Q3 2022 | $1.65 | $3.96 | 2.31 | $3.61 B | $4.09 B |
| 08/10/2022 | Q2 2022 | $1.55 | $2.89 | 1.34 | $2.93 B | $3.16 B |
| 05/11/2022 | Q1 2022 | $0.91 | $0.71 | -0.2 | $2.02 B | $2.12 B |
| 02/16/2022 | Q4 2021 | $5.30 | $1.10 | -4.2 | $2.55 B | $2.62 B |
| 11/10/2021 | Q3 2021 | $0.11 | $1.36 | 1.25 | $2.17 B | $2.31 B |
| 08/11/2021 | Q2 2021 | $0.08 | $0.47 | 0.39 | $1.70 B | $1.97 B |
| 05/05/2021 | Q1 2021 | $0.23 | $1.68 | 1.45 | $1.39 B | $1.58 B |
| 03/29/2021 | Q4 2020 | N/A | $0.88 | N/A | $1.77 B | $2.04 B |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Genmab A/S Earnings: FAQ's
Genmab A/S has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 6th, 2025 based offlast year's report dates.
In the previous quarter, Genmab A/S (:GMAB) reported $0.65 earnings per share (EPS) to beat the analysts' consensus estimate of $0.48 by $0.17.
The conference call for Genmab A/S's latest earnings report can be listened to online.
The conference call transcript for Genmab A/S's latest earnings report can be read online.
Genmab A/S (:GMAB) has a recorded annual revenue of $21.53 B.
Genmab A/S (:GMAB) has a recorded net income of $7.84 B.Genmab A/S has generated $12.14 earnings per share over the last four quarters.
Genmab A/S (:GMAB) has a price-to-earnings ratio of 14.75 and price/earnings-to-growth ratio is 1.44.